UCL 1684 dibromide
Cat. No.：YN1570020
| 产品名称: | UCL 1684 dibromide |
| CAS No.: | 199934-16-2 |
| Chemical Name: | 6,12,19,20,25,26-Hexahydro-5,27:13,18:21,24-trietheno-11,7-metheno-7H-dibenzo [b,n] [1,5,12,16]tetraazacyclotricosine-5,13-diium Dibromide; 6,12,19,20,25,26-Hexahydro-5,27:13,18:21,24-trietheno-11,7-metheno-7H-dibenzo [b,n] [1,5,12,16]tetraazacyclotricosi |
| Synonyms: | |
| 分子量: | 654.44 |
| 分子式: | C34H30Br2N4 |
| SMILES: | C12=[N+](CC3=CC(C[N+]4=CC=C(NCC5=CC=C(C=C5)CN6)C7=CC=CC=C47)=CC=C3)C=CC6=C1C=CC=C2.[Br-].[Br-] |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | UCL 1684 (dibromide) 是一种小电导钙活化钾 (SK) 通道阻滞剂。由于有效的心房选择性抑制 INa，UCL 1684 (dibromide) 在预防房颤发展方面是有效的。UCL 1684 (dibromide) 导致心房选择性 ERP 延长，继发于极化后耐药的诱导。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Chen, J-Q.
et al.: J. Med. Chem., 43, 3478 (2000)
Diness, J., et al.:Circ. Arryhthm. Electrophysiol., 3, 380 (2010)
